Tweets
Allopurinol during acute attacks does not worsen attacks or outcomes.
For more gout content, follow our Gout: More than Flares campaign at https://t.co/lQoiFjubZJ, https://t.co/PcOGD8umRw
Dr. John Cush @RheumNow ( View Tweet )
42 minutes 17 seconds ago
When Gout Flares, So Does the Cardiovascular System
We have spent decades teaching that a gout flare is a joint problem: a hot, swollen, painful joint that we treat with anti-inflammatory drugs and move on from (i.e., the treat to avoid symptoms strategy). The campaign title https://t.co/HCUQVaor4f
Dr. John Cush @RheumNow ( View Tweet )
1 hour 57 minutes ago
Yesterday the EMA approved upadacitinib (Rinvoq) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo - the 1st therapy approved for the most common form of vitiligo. Based on positive results from the Phase 3 Viti-Up trials https://t.co/MMv5LjZclQ https://t.co/zN41GC5T15
Dr. John Cush @RheumNow ( View Tweet )
3 hours 28 minutes ago
Upgrading & Maximizing the Classics
Panelists: Dr. Angelo Gaffo Dr. Lisa Stamp Dr. Michael Pillinger Dr. Ted Mikuls Dr. Jack Cush (moderator)
https://t.co/gO4CQD2f19 https://t.co/ESSLL0iK8F
Dr. John Cush @RheumNow ( View Tweet )
3 hours 56 minutes ago
2 T2T RCTs of 383 gout pts starting allopurinol - 31% had tophi. At 12 mos achieving target uric acid (<0.36mmol/L) was same in pts with and without tophi (70.3 vs 73.6), as was the %gout flares in month 11 (71.4% vs 79.7%; p=0.21). Allopurinol T2T success not influenced by https://t.co/zr7K8Y2Bqz
Dr. John Cush @RheumNow ( View Tweet )
5 hours 27 minutes ago
Gout patients have ↑ Cancer risk and ↓ risk of Parkinsons.
For more gout content, follow our Gout: More than Flares campaign at https://t.co/lQoiFjubZJ, https://t.co/dJrXMFb9OS
Dr. John Cush @RheumNow ( View Tweet )
6 hours 54 minutes ago
Chikungunya Club Meeting (7.24.2026)
Dr. Jack Cush reviews the news, journal reports from the past week on RheumNow. Take this week's RheumIQ quiz to test your knowledge!
https://t.co/UNoKMdclnj https://t.co/XpGfx1fJLu
Dr. John Cush @RheumNow ( View Tweet )
20 hours 56 minutes ago
Swimming Reduces Disability from Low Back Pain
Swimming is commonly recommended for patients with chronic low back pain. Yet, there is little trial data investigating swimming. An Australian study has shown for the first time that a program of swimming can be clinically https://t.co/OfxsvRjyJg
Dr. John Cush @RheumNow ( View Tweet )
22 hours 27 minutes ago
"The best medicine I know for rheumatism is to thank the Lord that it ain't the gout."
— Josh Billings (Henry Wheeler Shaw)
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Evidence-Based Dietary Recommendations for Gout
Gout, historically referred to as the “disease of kings,” was once associated with a lifestyle of excess. Today, it is more appropriate to refer to gout as a “disease of commoners,” as it is the most common inflammatory arthritis https://t.co/uIrSeOjxJZ
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
3 Rx are FDA approved for hidradenitis supprativa (secukinumab, adalimumab, bimekizumab). New JAK1i Povorcitinib in STOP-HS1 and STOP-HS2 ph 3 PCTs (608/619 pts). Povo showed HiSCR50 ~42% vs PBO 29% @wk12. AE: acne, pharyngitis https://t.co/n3FJUOjNuo https://t.co/9YAmPqW44z
Dr. John Cush @RheumNow ( View Tweet )
1 day 3 hours ago
Interferon-α as an Immunologic Driver of Sjögren's Disease
Using data from a Sjogren's registry, researchers have shown that IFNα drives Sjögren's disease, and can be elevated a decade before diagnosis. This study assessed the role of type 1 interferon (IFNα) in its onset and https://t.co/0BDDvR5cUB
Dr. John Cush @RheumNow ( View Tweet )
1 day ago


